End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.939 EUR | -.--% | -.--% | -.--% |
06-24 | Sector Update: Health Care Stocks Advance Monday Afternoon | MT |
06-24 | Sector Update: Health Care | MT |
Sales 2024 * | 407K 444K 34.21M | Sales 2025 * | 1.37M 1.49M 115M | Capitalization | 89.56M 97.62M 7.53B |
---|---|---|---|---|---|
Net income 2024 * | -45M -49.05M -3.78B | Net income 2025 * | -61M -66.49M -5.13B | EV / Sales 2024 * | 93.4 x |
Net cash position 2024 * | 51.55M 56.19M 4.33B | Net cash position 2025 * | 7.3M 7.95M 613M | EV / Sales 2025 * | 60 x |
P/E ratio 2024 * |
-2.06
x | P/E ratio 2025 * |
-1.77
x | Employees | 62 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on InflaRx N.V.
Managers | Title | Age | Since |
---|---|---|---|
Renfeng Guo
FOU | Founder | 53 | 30/11/07 |
Niels Riedemann
FOU | Founder | 51 | 30/11/07 |
Thomas Taapken
DFI | Director of Finance/CFO | 59 | 30/09/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicolas Fulpius
FOU | Founder | 51 | 30/11/07 |
Niels Riedemann
FOU | Founder | 51 | 30/11/07 |
Renfeng Guo
FOU | Founder | 53 | 30/11/07 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- IFRX Stock
- IF0 Stock